Company intelligence / Profile preview

Ferring Pharmaceuticals

Saint Prex, Switzerlanden.wikipedia.org ↗
Ownership
Private
Employees
~7000
Development stage
Commercial
01

Overview

Ferring has a broad commercial portfolio with multiple approved products in reproductive medicine, maternal health, gastroenterology, urology, and emerging areas like the human microbiome. Recent clinical successes include FDA approvals for Adstiladrin® (nadofaragene firadenovec-vncg) for high-risk BCG-unresponsive NMIBC and Rebyota® for recurrent C. difficile infection. The company continues to invest heavily in R&D (~15% of revenue), with ongoing late-stage programs in gene therapy and live biotherapeutics.

Therapeutic areas
Women's HealthOncologyGastroenterology
Modalities
Small moleculesHormones/peptides (e.g., oxytocin, vasopressin)AAV-based gene therapyFusion proteinsMicrobiome-based live biotherapeutics
Industry
Biotech
02

Drug pipeline

46 assets

sorbitol

Approved

45 more assets in the full pipeline.

Request access →
03

Partnerships

Blackstone Life Sciences – joint investment/spinoff “Fergene” for late-stage NMIBC gene therapy developmentVarious academic collaborations through product development programsStrategic acquisitions including Savient’s BTG business & Seikagaku’s Condoliase asset

Beyond the preview

Go deeper on Ferring Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ferring Pharmaceuticals.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call